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Uterine leiomyomata (fibroids) are the
commonest benign pelvic tumours. Therapeutic
optionsincludehormonemanipulationorsurgical
management, myomectomy ifthe patient wishes
to retain fertility, or hysterectomy. We describe
the use oftranscatheter arterial embolisation in a
patientwhopresentedwithalargeuterine fibroid
and pressure symptoms.
CASE REPORT A forty-two year old female
patient presented with acute urinary retention.
She was admitted to hospital where a urethral
catheter was passed. She described a several
month history of occasional difficulty
commencing the flow ofurine but was otherwise
well with no relevant past medical history.
Initial assessment included ultrasound, which
showedalargeuterinefibroidlyingattheposterior
aspect ofthe uterus, with a diameter in excess of
ten centimetres. Hypervascularity was observed
on colour doppler imaging. After discussion of
therapeutic alternatives with the patient, we
decided on transcatheter percutaneous
embolisation of the uterine arteries.
Prior to the procedure a prophylactic iv bolus of
cefuroxime (750 mg) and metronidazole (400
mg) was given. The procedure was performed
under conscious sedation (midazolam and
fentanyl) with physiological monitoring.
An initial puncture was performed at the right
common femoral artery and a 5-French arterial
sheath was placed. A 5-French pigtail catheter
was placed in the aorta, and pelvic angiography
demonstrated enlarged uterine arteries with
multiple dilated abnormal tortuous vessels,
corresponding to the uterine fibroid (fig 1).
The aorticbifurcation was thencrossedusing a5-
French Cobra II catheter, (Cordis, Roden, the
Netherlands). Theinternaliliacarterywasselected
and subsequently the left uterine artery was
cannulated using the road mapping facility
available on angiographic equipment. Polyvinyl
alcohol (PVA) foam particles of size 500 to 710
microns (Cook, Bloomington, In) were mixed
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Fig 1. Pelvic Arteriogram: Multiple, dilated, tortuous
vessels are identified centrally within the pelvis
corresponding to the large uterine fibroid.
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with dilute contrast media and were slowly
injected under fluoroscopic guidance until flow
in the left uterine artery was abolished.
A 5-French Sos-Omni selective catheter (Angio-
Dynamics, Queensbury, NY) was then used
throughthe arterial sheathto selecttheipsilateral
rightinternaliliacartery. Aguidewirewasplaced
distally within this artery and an exchange was
performed for a Cobra catheter. Again PVA
particleswereinjectedslowlywithdilutecontrast
medium, untilflow intherightuterine arterywas
also abolished.
A repeat pelvic angiogram was performed and
this demonstrated continued minimal filling of
both uterine arteries. The procedure was then
performed for a second time in each artery with
furtherembolisationusingPVAparticles.Asmall
pledget of Gelfoam (Upjohn, Kalamazoo, MI)
was placed at the origin of each uterine artery.
Following this procedure pelvic angiography
demonstrated occlusion of both uterine arteries,
withnoevidenceoffillingoftheabnormaluterine
fibroid vessels. (fig. 2)
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Fig 3. Ultrasound ofpelvis: The large uterine fibroid is
well seen. Multiple echogenic (bright) foci
represent aggregates of embolic material.
Approximately onehourfollowingtheprocedure
the patient developed episodes of sweating and
shiveringduetothepostembolisation syndrome;
she was treated using diclofenac sodium, 50 mg
suppository. These symptoms resolved over two
hoursandthepatientwasdischargedthefollowing
morning.
At six weeks, ultrasound examination
demonstrated aseventy-five percentreduction in
the total volume ofthe fibroid. She has reported
no further symptoms.
DISCUSSION
Initial reports of devascularisation of the uterus
detail an effective means of controlling
postpartumhaemorrhage.1Highsuccessrateshave
been described with uterine artery ligation in
both postpartum and post-caesarean section
bleeding. As a logical extension to this,
percutaneoustranscatheterembolisationhasbeen
used effectively in several situations, including
postpartum bleeding, uterine arterio-venous
malformation2 and gynaecological malignancy
bleeding.3Complicationratesfortheseprocedures
are low andtheoption ofsurgeryis still available
should success not be obtained.
Uterine leiomyomata (fibroids) are commonly
asymptomatic, althoughuterineenlargement can
result in pressure symptoms with heaviness and
discomfort. Infarction or torsion may result in
pelvic pain. Haemorrhage is a common
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complication, presumably due at least partly to
the hypervascularity of a uterine fibroid.
Intheory,uterinefibroids shouldbeideally suited
toembolisation as they derive theirblood supply
almost exclusively from the uterine arteries. The
vascular patterns of myomatous uteri have been
well described previously: essentially there is a
peripheral supply oftortuous and dilated vessels
from which arise arteries that supply the central
part ofthe fibroid. The peripheral supply results
in a dense persistent tumour blush on
angiography.4 As clear anastomoses occur
between the left and right uterine artery, both
vessels mustbeembolisedtoobtainasatisfactory
technical result. In addition, there is evidence
that there is devascularisation ofuterine fibroids
in women who respond well to treatment with
hormonal agents (including synthetic
progestogens andLHRH agonists). Investigation
with doppler ultrasound has demonstrated some
devascularisation offibroids in womenwhohave
responded well to treatment with hormonal
therapy.5 This further supports the argument for
percutaneousembolisationoftheuterinearteries.
Few previous reports of uterine fibroid
embolisation exist. However, Ravina et al.
described a series of sixteen patients, of whom
fourteen had heavy and prolonged bleeding, and
whounderwentuterine arterial embolisation.6 At
a mean follow-up of twenty months, symptoms
hadentirely resolved ineleven patients and were
partiallyrelievedinthree. Allhadbeenpreviously
treatedwithhormonaltherapy, withonlytransient
success. Goodwin et. al. at the University of
California, LosAngeles,describedthistechnique
in eleven patients.7 Eight of nine patients, who
they were able to follow up, reported noticeable
symptomatic improvement at six months.
One potential benefit of percutaneous
embolisation is the preservation of normal
anatomical structures andthereforefertility.Most
ofthepatientsintheFrenchstudy, (Ravinaet. al.)
returned to normal menstruation, and indeed one
conceived after fifteen months. It would be
prudent to await long-term follow-up in larger
clinical trials to fully appreciate the long-term
potentialbenefit,bothwithrespecttothetreatment
oftheuterinefibroidsandpreservationoffertility.
Inconclusion, percutaneous transcatheteruterine
arterial embolisationoffers ausefulalternativeto
surgery in the treatment of uterine fibroids.
Potential benefits over surgery include reduced
post-operativecomplications,lowercosts,shorter
hospitalisation and the potential preservation of
fertility. Although short-term results have been
excellent in our case, and in the two previously
described short series6' 7 further work will be
necessary with large controlled trials to assess
long-term benefit.
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